Injektionsglottoplastik

Die eingeschränkte Stimmleistung ist das Hauptsymptom der glottalen Insuffizienz. Dazu können Schluckbeschwerden, Atemnot beim Sprechen sowie eine verminderte allgemeine Leistungsfähigkeit kommen. Die Injektionsglottoplastik ist eine mögliche interventionelle Therapieoption.

Abstract

Glottal insufficiency often causes voice problems, but also dysphagia, dyspnoe while speaking as well as a limited global strength and endurance. Injection glottoplasty represents a valid therapeutic option. This article describes indication, materials, technique, and outcome expectations. For selection of the appropriate material and technique morphological changes and parameters of vocal function should be considered.

Fazit

Die Injektionsglottoplastik ist eine gute Option zur Behandlung der glottalen Insuffizienz. Der behandelnde Arzt sollte Vor- und Nachteile der vorhandenen Materialen und Techniken genau kennen, um die für den Patienten bestmögliche Therapieoption anwenden zu können.

Schlüsselwörter

Stimmlippenaugmentation - Stimmlippenlähmung - Vocalisatrophie - glottale Insuffizienz

Keywords

vocal fold augmentation - vocal fold paralysis - glottal insufficiency

• Literatur

• 1 Tigges M, Hess M. Glottis injection to improve voice function. HNO 2015; 63: 489-496
• 2 Anderson TD, Mirza N. Immediate percutaneous medialization for acute vocal fold immobility with aspiration. Laryngoscope 2001; 111: 1318-1321
• 3 Sato K, Umeno H, Nakashim T. Autologous fat injection laryngohypopharyngoplasty for aspiration after vocal fold paralysis. Ann Otol Rhinol Laryngol 2004; 113: 87-92
• 4 Simpson B, Rosen C. Operative Techniques in Laryngology. Springer Verlag; 2008
• 5 Mallur PS, Rosen CA. Vocal fold injection: review of indications, techniques, and materials for augmentation. Clin Exp Otorhinolaryngol 2010; 3: 177-182
• 6 Nawka T, Hosemann W. Voice disorder. Surgical procedures. Laryngorhinootologie 2005; 84 (Suppl. 01) S201-S212
• 7 Hu HC. et al. Office-based Autologous Fat Injection Laryngoplasty for Vocal Process Granuloma. J Voice 2016; 30: 758 e7-758 e11
• 8 van den Broek EMJM, Vokes DE, Dorman EB. Bilateral In-Office Injection Laryngoplasty as an Adjunctive Treatment for Recalcitrant Puberphonia: A Case Report and Review of the Literature. Journal of Voice 2016; 30: 221-223
• 9 Mastronikolis NS. et al. Medialization thyroplasty for voice restoration after transoral cordectomy. Eur Arch Otorhinolaryngol 2013; 270: 2071-2078
• 10 Carroll TL, Rosen CA. Trial vocal fold injection. J Voice 2010; 24: 494-498
• 11 Young VN, Gartner-Schmidt J, Rosen CA. Comparison of voice outcomes after trial and long-term vocal fold augmentation in vocal fold atrophy. Laryngoscope 2015; 125: 934-940
• 12 Miaskiewicz B. et al. Assessment of acoustic characteristics of voice in patients after injection laryngoplasty with hyaluronan. Otolaryngol Pol 2016; 70: 15-23
• 13 Rosen CA. et al. Vocal fold augmentation with calcium hydroxylapatite: twelve-month report. Laryngoscope 2009; 119: 1033-1041
• 14 Caffier PP. et al. The use of injectable calcium hydroxylapatite in the surgically pretreated larynx with glottal insufficiency. Laryngoscope 2017; 127: 1125-1130
• 15 Prantl L. et al. Current Perceptions of Lipofilling on the Basis of the New Guideline on “Autologous Fat Grafting”. Handchir Mikrochir Plast Chir 2016; 48: 330-336
• 16 Hartl DM. et al. Long-term acoustic comparison of thyroplasty versus autologous fat injection. Ann Otol Rhinol Laryngol 2009; 118: 827-832
• 17 Truzzi GM. et al. Methods of Fat Tissue Processing for Human Vocal Fold Injection: A Systematic Review. J Voice 2017; 31: 244 e17-244 e21
• 18 Zelenik K. et al. Comparison of long-term voice outcomes after vocal fold augmentation using autologous fat injection by direct microlaryngoscopy versus office-based calcium hydroxylapatite injection. Eur Arch Otorhinolaryngol 2017; 274: 3147-3151
• 19 Rihkanen H. Vocal fold augmentation by injection of autologous fascia. Laryngoscope 1998; 108: 51-54
• 20 Kinnari TJ, Pietarinen P, Geneid A. Vocal fold augmentation under local anaesthesia using autologous fascia. Clin Otolaryngol 2018; 43: 989-991
• 21 Bergamini G. et al. Therapy of unilateral vocal fold paralysis with polydimethylsiloxane injection laryngoplasty: our experience. J Voice 2010; 24: 119-125
• 22 Sittel C. et al. Polydimethylsiloxane particles for permanent injection laryngoplasty. Ann Otol Rhinol Laryngol 2006; 115: 103-109
• 23 Mallur PS. et al. Safety and efficacy of carboxymethylcellulose in the treatment of glottic insufficiency. Laryngoscope 2012; 122: 322-326
• 24 Chen YY. et al. Fat augmentation for nonparalytic glottic insufficiency. ORL J Otorhinolaryngol Relat Spec 2003; 65: 176-183
• 25 Hsiung MW. et al. Autogenous fat injection for vocal fold atrophy. Eur Arch Otorhinolaryngol 2003; 260: 469-474
• 26 Lodder WL, Dikkers FG. Comparison of voice outcome after vocal fold augmentation with fat or calcium hydroxylapatite. Laryngoscope 2015; 125: 1161-1165
• 27 Chen X. et al. Types and timing of therapy for vocal fold paresis/paralysis after thyroidectomy: a systematic review and meta-analysis. J Voice 2014; 28: 799-808